Georgea Sisson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Georgea sisson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Georgea Sisson Today - Breaking & Trending Today

Chutes & Ladders—Zimmer Biomet calls on Medtronic vet Jamali to lead spinout


Samir Mody as chief commercial officer, while 
Friedrich Asmus signs on as SVP, clinical development and medical affairs. Meanwhile, the company has also tapped 
Joel Centeno as SVP, manufacturing, quality and supply chain. Mody comes over from Medtronic, where he was vice president, CRHF strategy, health economics and reimbursement. Asmus previously served as VP of clinical development at ophthalmology biotech ProQR Therapeutics, while Centeno comes over after stints at Boston Scientific, Hologic and AltheaDx.
Tamra Adams as chief financial officer, a newly created executive position at the company. Before joining Antios, Adams founded Accounting Concepts, which provided CFO, accounting, and financial services to emerging growth companies in the biopharmaceutical and information technology industries, including Engage Therapeutics. ....

United States , United Kingdom , Matteo Levisetti , Aeglea Biotherapeutics , Fraiser Kansteiner , Friedrich Asmus , Tamra Adams , Mcdavid Stilwell , Zimmer Biomet , Pharmas Roche , Rockley Photonics , Bridget Okeeffe , Robert Kern , Peter Calveley , Natalie Holles , Saurabh Saha , Georgea Sisson , Charles Albright , Moncef Slaoui , Richard Kim , Petra Kaufmann , Joel Centeno , Francesco De Rubertis , Coherus Biosciences , Samir Mody , Vafa Jamali ,

Lyra Therapeutics Announces Appointment of Robert Kern, MD, as Chief Medical Officer


Published: Feb 17, 2021
 
Thought leader in the ENT treatment community brings insight from clinical practice to next stage of development for LYR-210 and pipeline
 
WATERTOWN, Mass. (BUSINESS WIRE) Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today announced that Robert Kern, MD has been named Chief Medical Officer. He will also remain in his current position as the George A. Sisson Professor and Chair, Department of Otolaryngology – Head and Neck Surgery, Northwestern University Feinberg School of Medicine. Dr. Kern is the immediate past president of the ....

United States , Georgea Sisson , Robert Kern , Maria Palasis , Wayne State University , International Society Of Inflammation , Jefferson Medical College Of Thomas University , National Institutes Of Health , Northwestern University Feinberg School Of Medicine , Georgetown University , Department Of Otolaryngology , Lyra Therapeutics Inc , American Rhinologic Society , Chief Medical , Neck Surgery , Northwestern University Feinberg School , International Society , Chief Medical Officer , Jefferson Medical College , Thomas Jefferson University , National Institutes , Private Securities Litigation Reform Act , Quarterly Report , Lyra Therapeutics Announces Appointment Of Robert Kern , Was Chief Medical Officer , ஒன்றுபட்டது மாநிலங்களில் ,